Advertisement

Picture [iito] Made Without Love 650x80px
Document › Details

Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen.

Organisations Organisation Orphazyme A/S (Nasdaq Copenhagen: ORPHA.CO)
  Group Orphazyme (Group)
  Organisation 2 Novo Holdings A/S
  Group Novo Group (Group)
Products Product arimoclomol
  Product 2 investment banking
Index term Index term Orphazyme–SEVERAL: investment, 202002 directed issue + private placement DKK745m (€100m) of 7m new + existing shares
Persons Person Stratton, Kim (Orphazyme 202002 CEO)
  Person 2 Vadsholt, Anders (TopoTarget 201011 CFO)
     


   
Record changed: 2020-02-12

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Orphazyme (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top